| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5846ed1722d0bb1186befbfb2b991232 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00868
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00897 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008 |
| filingDate |
2017-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b3257973cc7224bf22e6db7e2d23bbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b06f7c25a8cdfc78ab230b62afaf89f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8f9182bd141f8e8b2c79d1a71c0d455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6285a8c5db917f6b4ff02e62a021b3d4 |
| publicationDate |
2019-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2019117461-A1 |
| titleOfInvention |
Method for minimally invasive, cell-selective laser therapy on the eye |
| abstract |
A method for a minimally invasive, cell-selective laser therapy on the eye. The method, based on a short-pulse laser system, allows for different selective types of therapy on the eye. The method is based on a frequency-doubled, continuously working solid-state laser including a pump source and a control unit. The control unit regulates the pump source such that the solid-state laser emits individual pulses with pulse lengths ranging from 50 ns to continuous, wherein pulse lengths ranging from 50 ns to 50 μs are provided for selective therapies and pulse lengths ranging from 50 μs to continuous are provided for coagulative or stimulating therapies, in particular in the range from 1 ms to 500 ms. The proposed method enables a selective treatment of melanin-containing cells in the different areas of the eye via the targeted control of the pump source. |
| priorityDate |
2016-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |